Chemical formula: C₁₅H₁₁I₄NO₄ Molecular mass: 776.87 g/mol PubChem compound: 5819
Levothyroxine sodium is used for the treatment of hypothyroidism. The chief action of levothyroxine is to increase the rate of cell metabolism.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
ATC code | Group title | Classification |
---|---|---|
H03AA01 | Levothyroxine sodium | H Systemic hormonal preparations, excl. Sex hormones and insulins → H03 Thyroid therapy → H03A Thyroid preparations → H03AA Thyroid hormones |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
Title | Information Source | Document Type | |
---|---|---|---|
LEVOXYL Tablet | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
ELTROXIN Tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
SYNTHROID Tablet | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
LEVOTHYROXINE Oral solution | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Levothyroxine is an active ingredient of these brands:
United States (US)Albania (AL)
Austria (AT)
Brazil (BR)Cyprus (CY)
Ecuador (EC)Estonia (EE)
Finland (FI)
France (FR)Germany (DE)
Israel (IL)Italy (IT)
Japan (JP)
Lithuania (LT)
Malta (MT)Mexico (MX)Netherlands (NL)
New Zealand (NZ)Poland (PL)
Romania (RO)
Singapore (SG)South Africa (ZA)Tunisia (TN)
Turkey (TR)United Kingdom (UK)
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.